Skip to Main Content
Qurgen Qurgen
Menu Button

Dec. 2022

Brand Icon
Suzhou Fuent Pharmaceutical Co., Ltd. completed its first round of financing with RMB 125 million fully received, valuing the company at RMB 575 million post-investment.

Recent important news

Mar. 2026
Qurgen is happy to announce that the blood and biopsy tissue results of a late-stage of ocular melanoma...
Learn More
Jan. 13, 2026
Dr. Chai Yan Joins Qurgen/Fuent as Senior Vice President for BP，Qurgen, CEO，Suzhou Fuent Pharmaceutics and...
Learn More